Dong-Il Kim
Fortune : 5 690 $ au 31/08/2026
Fortune : 5 690 $ au 31/08/2026
Dong-Il Kim is currently an Independent Director at SunBio, Inc. since 2025 and a Professor at Inha University since 2012.
Former positions include Independent Director roles at SunBio, Inc. and Celltrion, Inc. Education includes a doctorate from Rutgers State University of New Jersey conferred in 1989, and undergraduate and graduate degrees from Seoul National University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SUNBIO, INC. 0,01 % | 30/09/2025 | 1 250 ( 0,01 % ) | 5 690 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SUNBIO,INC. | Directeur/Membre du Conseil | 31/03/2025 |
Inha University
Inha University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/06/2011 |
| Sociétés | Poste | Fin |
|---|---|---|
| SUNBIO,INC. | Directeur/Membre du Conseil | - |
| CELLTRION, INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SunBio, Inc.
SunBio, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies biopharmaceuticals, bio-similars and medical devices | Health Technology |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inha University
Inha University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltrion, Inc.
Celltrion, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national